Key result
Age 70 and older linked to ~81% higher overall mortality in retroperitoneal liposarcoma.
Why the study?
This study attempted to evaluate the clinical features and prognostic factors of elderly patients with retroperitoneal liposarcoma and establish a nomogram to predict overall survival.
What are the clinical features and prognostic factors for overall survival in elderly patients with retroperitoneal liposarcoma?
Cohort (n=992)
What are the clinical features and prognostic factors for overall survival in elderly patients with retroperitoneal liposarcoma?
Absolute Event Rate: 41.58% vs 22.94%
p-value: p=<0.001
A newly developed nomogram incorporating age, histological type, AJCC stage, and surgery accurately predicts 1-, 3-, and 5-year overall survival in elderly patients with retroperitoneal liposarcoma, outperforming the standard AJCC staging system.
Nomogram may refine prognostication in elderly retroperitoneal liposarcoma; hypothesis-generating and requires external validation before clinical adoption.
Background: This study attempted to evaluate the clinical features and prognostic factors of elderly patients with retroperitoneal liposarcoma (RLS) and establish a nomogram to predict overall survival (OS). Methods: Patients diagnosed with RLS from 2010 to 2015 were identified from the Surveillance Epidemiology and End Results database. Clinical features and prognostic factors were examined, and a nomogram was constructed. Results: There were many differences between the elderly patients with RLS and the young patients with RLS; these differences included marital status, surgery, radiation, chemotherapy, and OS (P<0.05). An analysis of prognostic factors showed that surgery, as the main treatment for elderly patients, can significantly improve prognosis. Histological type and AJCC stage also had a significant effect on OS. Unlike the young group, age was an independent prognostic factor for the elderly. Nomograms for the elderly population were developed based on these prognostic factors. The C-indexes of the 1-, 3- and 5-year survival nomograms were 0.737 (95% CI 0.692-0.782), 0.737 (0.692-0.782) and 0.7367 (0.692-0.782), and the AUCs at 1, 3, and 5 years were 0.749, 0.804 and 0.810, respectively. Further results demonstrate the superiority of this approach in risk stratification over the AJCC staging system. Conclusions: Elderly patients with RLS are a particular group of individuals who are distinct from young patients in many clinical characteristics, and the constructed nomograms could accurately predict OS in elderly patients with RLS.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2021) conducted a cohort in Retroperitoneal liposarcoma (n=992). Elderly age (≥70 years) vs. Young age (<70 years) was evaluated on Overall mortality (p=<0.001). Elderly patients (≥70 years) with retroperitoneal liposarcoma had a significantly higher overall mortality rate compared to younger patients (41.58% vs 22.94%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: